ZAVAMET 500 MG (Metformin (500mg) + Vildagliptin (50mg))
-15%

ZAVAMET 500 MG (Metformin (500mg) + Vildagliptin (50mg))

Original price was: ₹125.60.Current price is: ₹107.20.

Placeholder

Original price was: ₹125.60.Current price is: ₹107.20.

Add to cart
Buy Now
Category: Tag:

Zavamet 500 Tablet combines two active ingredients that aid in managing elevated blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This medication is instrumental in mitigating severe complications associated with diabetes, such as damage to the kidneys and potential vision loss, while also lowering the risk of cardiovascular events like heart attacks and strokes. It can be utilized on its own or in conjunction with other anti-diabetes drugs. The efficacy of all diabetes treatments is enhanced when coupled with a balanced diet and consistent physical activity. The prescribed dosage of Zavamet 500 will be tailored to your specific health status, current blood sugar readings, and any other medications you are taking. It is advisable to take the tablet during meals to lessen the likelihood of gastrointestinal discomfort. Consistency is key; aim to take the medication at the same time each day for optimal results, and refrain from discontinuing use without your healthcare provider’s guidance. This medication is designed to help manage your blood sugar effectively and avert long-term complications. While on Zavamet, adhering to the dietary and exercise plans advised by your healthcare professional is essential, as lifestyle choices significantly impact diabetes control. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.

Reviews

There are no reviews yet.

Be the first to review “ZAVAMET 500 MG (Metformin (500mg) + Vildagliptin (50mg))”

Your email address will not be published. Required fields are marked *

Top